Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial

submitted by: efung
BACKGROUND: Patients with thalassemia major (Thal) frequently have low plasma zinc, which has been associated with low bone mass. OBJECTIVE: The objective was to determine the effect of zinc supplementation on bone mass in patients with Thal. DESIGN: Forty-two subjects (21 females aged 10-30 y) with Thal and low bone mass were randomly assigned to receive 25 mg Zn/d or placebo. Bone mineral content (BMC) and areal bone mineral density (aBMD) were assessed by using dual-energy X-ray...
Authors: Ellen B. Fung, Janet L. Kwiatkowski, James N. Huang, Ginny Gildengorin, Janet C. King, Elliott P. Vichinsky

Beating cancer via video game

submitted by: mdanderson
Steven Gonzalez, a patient at MD Anderson Children's Cancer Hospital, sees video games as a healing power rather than simply entertainment. When he began leukemia treatment as a young teenager, he felt separated from his peers and the normalcy of life. For Gonzalez, video games provided him a link to the world he knew before. To help other young cancer patients not feel so isolated, he created a cancer-fighting video game. He also joined patient committees at MD Anderson Children's Cancer...

Tanning beds increase risk of skin cancer for teens

submitted by: mdanderson

The World Health Organization lists indoor tanning beds and lamps as carcinogens, yet many teenagers continue to believe that indoor tanning helps them look their best. Dennis Hughes, M.D., Ph.D., associate professor in Pediatrics at The University of Texas MD Anderson Cancer Center, explains how tanning beds increase your risk of developing skin cancers such as squamous cell carcinoma, basal cell carcinoma and melanoma, the most deadly form.

Targeted Lymphoma Drug Works After Others Fail

submitted by: mdanderson

MD Anderson's Dr. Michelle Fanale, Hodgkin lymphoma survivor Alexandra Medina and research nurse Rinata Simien talk about newly approved drug brentuximab vedotin.